Skip to main content
Lyn Duncan, MD, Pathology, Boston, MA, Massachusetts General Hospital

LynMcdivittDuncanMD

Pathology Boston, MA

Dermatopathology, Anatomic Pathology, Clinical Pathology

Professor of Pathology, Harvard Medical School

Dr. Duncan is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Duncan's full profile

Already have an account?

Education & Training

  • Brigham and Women's Hospital/Harvard Medical School
    Brigham and Women's Hospital/Harvard Medical SchoolFellowship, Dermatopathology, 1990 - 1991
  • Washington University/B-JH/SLCH Consortium
    Washington University/B-JH/SLCH ConsortiumResidency, Pathology-Anatomic and Clinical, 1986 - 1990
  • Washington University in St. Louis School of Medicine
    Washington University in St. Louis School of MedicineClass of 1986

Certifications & Licensure

  • NY State Medical License
    NY State Medical License 2012 - 2026
  • ME State Medical License
    ME State Medical License 2016 - 2025
  • MO State Medical License
    MO State Medical License 1990 - 2025
  • VT State Medical License
    VT State Medical License 2013 - 2024
  • MA State Medical License
    MA State Medical License 1991 - 2024
  • GA State Medical License
    GA State Medical License 2013 - 2021
  • American Board of Pathology Anatomic Pathology
  • American Board of Pathology Dermatopathology

Publications & Presentations

PubMed

Lectures

  • Dermatopathology Update 
    Harvard Medical School ,Department Of Continuing Education, Boston, Massachusetts - 9/19/2013
  • Dermatopathology Update With Mini-Symposiums on Inflammatory Dermatoses and New Diagnostic Testings for Melanocytic Lesions 
    Harvard Medical School, Boston, Massachusetts - 9/20/2012

Press Mentions

  • Loss of GCNT2/I-branched Glycans Enhances Melanoma Growth and Survival
    Loss of GCNT2/I-branched Glycans Enhances Melanoma Growth and SurvivalAugust 22nd, 2018

Professional Memberships

Hospital Affiliations